Provenienza dei contatti di primo grado di Yasuji Furutani
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 29 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Yasuji Furutani tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| University of Tokyo | College/University | Graduate Degree Undergraduate Degree | |
| SUMITOMO CHEMICAL CO., LTD. | Chemicals: Specialty | Corporate Officer/Principal Corporate Officer/Principal | |
| ANGES, INC. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
| JCR PHARMACEUTICALS CO., LTD. | Pharmaceuticals: Major | President Director/Board Member | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Kyoto Pharmaceutical Industries Ltd.
 Kyoto Pharmaceutical Industries Ltd. Pharmaceuticals: MajorHealth Technology Kyoto Pharmaceutical Industries Ltd. engages in pharmaceutical products manufacturing. Its products include pharmaceuticals to regulate high-blood pressure, Ischemic heart disease treatment, digitalis formulation, and constipation remedies. The firm also develops and produces laxatives, anti-flatulence and anti-diarrheal medicines, and decongestants and cold medicines. The company was founded on September 5, 1946 and is headquartered in Kyoto, Japan. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director/Board Member Director/Board Member | |
GenomIdea, Inc.
 GenomIdea, Inc. BiotechnologyHealth Technology Part of ISHIHARA SANGYO KAISHA LTD., GenomIdea, Inc. engages in biopharmaceutical products development and distribution. The company is based in Ibaraki, Japan. GenomIdea was acquired by ISHIHARA SANGYO KAISHA LTD. from AnGes, Inc. on January 31, 2013 for $0.0 million. | Biotechnology | Director/Board Member | |
Nihon Medi-Physics Co., Ltd.
 Nihon Medi-Physics Co., Ltd. Pharmaceuticals: MajorHealth Technology Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura. | Pharmaceuticals: Major | Chief Executive Officer | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
AnGes USA, Inc.
 AnGes USA, Inc. Pharmaceuticals: MajorHealth Technology Part of AnGes, Inc., AnGes USA, Inc. develops and manufactures medicines. The company is based in Gaithersburg, MD. Ei Yamada has been the CEO of the company since 2014. | Pharmaceuticals: Major | Chief Executive Officer | |
Bristol-Myers Squibb KK
 Bristol-Myers Squibb KK BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb KK develops, manufactures and markets biopharmaceutical products. The company is based in Shinjuku-ku, Japan. | Biotechnology | Director/Board Member | |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | President | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
Sunovion Pharmaceuticals Europe Ltd.
 Sunovion Pharmaceuticals Europe Ltd. Pharmaceuticals: MajorHealth Technology Sunovion Pharmaceuticals Europe Ltd. is a British European pharmaceutical company founded in 2013 that is dedicated to improving the lives of patients through the supply of essential medicines. The company is based in London, UK. The company commercializes and distributes a portfolio of specialty brands and hospital products in 40 countries worldwide, both directly and through strategic partnerships. The company's vision is to become a recognized partner of choice through their commercial excellence, patient focus, and presence across the globe. Sunovion Pharmaceuticals Europe aims to have a positive impact on society through their pioneering focus on their environment, social, and governance (ESG) goals. | Pharmaceuticals: Major | Chief Executive Officer | |
Tolero Pharmaceuticals, Inc.
 Tolero Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Tolero Pharmaceuticals, Inc. manufactures and markets pharmaceutical products. It is a clinical-stage biopharmaceutical company with a single-minded purpose to alleviate human suffering through the development of medicines to treat cancer and other serious human diseases. The company is headquartered in Lehi, UT. | Pharmaceuticals: Other | Director/Board Member | |
| KOEI CHEMICAL COMPANY, LIMITED | Chemicals: Major Diversified | Comptroller/Controller/Auditor | |
| LIXIL CORPORATION | Building Products | Director/Board Member | |
Resona Bank Ltd.
 Resona Bank Ltd. Regional BanksFinance Resona Bank, Ltd. provides commercial banking services. It operates through the following segments: Personal, Corporate, and Market. The Personal segment handles financial services for individual customers including personal loans, asset management, and inherited asset consulting. The Corporate segment focuses on lending, asset management that uses trusts, real estate operations, enterprise pensions, and business growth support. The Market segment engages in funds, foreign and local exchanges, bonds, and derivatives. It also offers current and savings accounts, mortgages, debit and credit cards, pension and insurance products, online and phone banking, and investment trusts. The company was founded on May 15, 1918 and is headquartered in Osaka, Japan. | Regional Banks | Director/Board Member | |
| RESONA HOLDINGS, INC. | Regional Banks | Director/Board Member | |
| National Police Agency | General Government | Director/Board Member | |
| GURUNAVI, INC. | Internet Software/Services | Director/Board Member | |
FUJIFILM Toyama Chemical Co. Ltd.
 FUJIFILM Toyama Chemical Co. Ltd. Pharmaceuticals: OtherHealth Technology Part of FUJIFILM Holdings Corp., FUJIFILM Toyama Chemical Co. Ltd. brings innovative solutions to various industries such as healthcare, graphic systems, and digital imaging. The company is based in Tokyo, Japan. The Japanese company's core technologies include chemical, mechanical, optical, electronic, and imaging technologies. With revenues of $21 billion in 2020, the company is committed to responsible environmental stewardship and good corporate citizenship. The company was founded in 1968, and the CEO is Misao Tsuda. FUJIFILM Toyama Chemical Co. was acquired by FUJIFILM Holdings Corp. from Daiichi Sankyo Co., Ltd. on October 01, 2006. | Pharmaceuticals: Other | Director/Board Member | |
| MUTUAL CORPORATION | Industrial Machinery | Director/Board Member | |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member | |
| Pancreas Research Foundation of Japan | Chairman | ||
| Financial Services Agency | General Government | Corporate Officer/Principal | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member | |
Meltin MMI KK
 Meltin MMI KK Medical SpecialtiesHealth Technology Meltin MMI KK develops bio-signal interface technologies. It offers biosignal processing and cable-driven ststems. The company was founded by Sumio Ito, Masahoro Kasuya and Tatsuya Seki and is headquartered in Tokyo, Japan. | Medical Specialties | Director/Board Member | |
| Hiroshima University | College/University | Doctorate Degree | |
IMMD, Inc.
 IMMD, Inc. BiotechnologyHealth Technology IMMD, Inc. provides drug discovery research for pharmaceutical companies. It identifies drug seeds by virtual screening, to select promising seeds and to optimize the seeds by minimum syntheses, based on estimated docking mode to the target. The firm also establishes a drug discovery method using software system for rational drug design based on 3-D structures of target proteins. Its business activities also include collaborative drug discovery researches, in-house drug discovery program, and drug seeds. The company was founded by Akiko Itai on March 16, 1995 and is headquartered in Tokyo, Japan. | Biotechnology | Corporate Officer/Principal | |
| Sanno Shokuhin Corp. | Chairman | ||
| Indian Agricultural Research Institute | College/University | Graduate Degree | |
| Kyushu University | College/University | Graduate Degree | |
| SUMITOMO ELECTRIC INDUSTRIES, LTD. | Electrical Products | Director/Board Member | |
| NITTO DENKO CORPORATION | Electronic Equipment/Instruments | Director/Board Member | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Adelaide | College/University | Doctorate Degree | |
Apex Bioscience, Inc.
 Apex Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Apex Bioscience, Inc. develops patented products based upon hemoglobin and nitric oxide technologies. The company was founded by Joseph de Angelo on June 17, 1993 and is headquartered in Chapel Hill, NC. | Miscellaneous Commercial Services | Chief Operating Officer | |
DNX Corp.
 DNX Corp. Medical SpecialtiesHealth Technology DNX Corp. provides pre-clinical drug development services to the pharmaceutical and biotechnology industry. The private company is based in Princeton, NJ and has subsidiaries in Switzerland and France. The company was founded by John K. Clarke, Steven H. Holtzman. | Medical Specialties | Corporate Officer/Principal | |
Bio Response, Inc.
 Bio Response, Inc. Miscellaneous Commercial ServicesCommercial Services Bio Response, Inc. provides marketing and distribution services. The private company is based in Brooklyn, NY and has subsidiaries in the United States. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The North Carolina Biotechnology Center
 The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Internet Software/Services | Director/Board Member | |
| NEOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| DNX Bio-Therapeutics, Inc | Corporate Officer/Principal | ||
| Chaudhary Charan Singh University | College/University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Giappone | 29 |
| Stati Uniti | 16 |
| Regno Unito | 4 |
| India | 3 |
| Bermuda | 2 |
Settori
| Health Technology | 25 |
| Consumer Services | 7 |
| Commercial Services | 4 |
| Producer Manufacturing | 4 |
| Process Industries | 3 |
Posizioni
| Director/Board Member | 72 |
| Corporate Officer/Principal | 38 |
| Chief Executive Officer | 14 |
| President | 14 |
| Independent Dir/Board Member | 11 |
Contatti più connessi
- Borsa valori
- Insiders
- Yasuji Furutani
- Connessioni Società
